Evidence map›Paper›PMID 28053314›Full record

ArticleScientific reports2017

Comparative Transcriptome Profiles of Human Blood in Response to the Toll-like Receptor 4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A.

Liming Luan, Naeem K Patil, Yin Guo, Antonio Hernandez, Julia K Bohannon, Benjamin A Fensterheim, Jingbin Wang, Yaomin Xu, Perenlei Enkhbaatar, Ryan Stark and 1 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Intranasal Administration ofInternational journal of molecular sciences · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Screening key genes and microRNAs in sepsis by RNA-sequencing.Journal of the Chinese Medical Association : JCMA · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Liming LuanDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Naeem K PatilDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Yin GuoDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Antonio HernandezDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Julia K BohannonDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Benjamin A FensterheimDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Jingbin WangDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Yaomin XuDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Perenlei EnkhbaatarDepartment of Anesthesiology, the University of Texas Medical Branch, Galveston, TX, USA.
Ryan StarkDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
Edward R SherwoodDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt University Medical Center · USThe University of Texas Medical Branch at Galveston · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Augmentation of Innate Anti-Microbial Immunity by TLR4 AgonistsR01GM104306 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ENKHBAATAR, PERENLEI, SHERWOOD, EDWARD R · 2013 to 2016
$1.2M
Prevention of Endothelial Injury by Toll-like Receptor 4 ModulatorsK08GM117367 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STARK, RYAN J · 2015 to 2018
$734k
The effect of MPLA treatment on immune responses to infection after severe burnF32GM110811 · NIGMS · VANDERBILT UNIVERSITY · PI BOHANNON, JULIA K. · 2014 to 2014
$53k
NIGMS NIH HHS F32 GM110811NIGMS NIH HHS K08 GM117367NIGMS NIH HHS R01 GM104306NIGMS NIH HHS T32 GM007347
6 · The paper itself

Abstract

Monophosphoryl lipid A (MPLA), a less toxic derivative of lipopolysaccharide (LPS), is employed as a vaccine adjuvant and is under investigation as a non-specific immunomodulator. However, the differential response of human leukocytes to MPLA and LPS has not been well characterized. The goal of this study was to compare the differential transcriptomic response of human blood to LPS and MPLA. Venous blood from human volunteers was stimulated with LPS, MPLA or vehicle. Gene expression was determined using microarray analysis. Among 21,103 probes profiled, 136 and 130 genes were differentially regulated by LPS or MPLA, respectively. Seventy four genes were up-regulated and 9 were down-regulated by both ligands. The remaining genes were differentially induced by either agent. Ingenuity Pathway Analysis predicted that LPS and MPLA share similar upstream regulators and have comparable effects on canonical pathways and cellular functions. However, some pro-inflammatory cytokine and inflammasome-associated transcripts were more strongly induced by LPS. In contrast, only the macrophage-regulating chemokine CCL7 was preferentially up-regulated by MPLA. In conclusion, LPS and MPLA induce similar transcriptional profiles. However, LPS more potently induces pro-inflammatory cytokine and inflammasome-linked transcripts. Thus, MPLA is a less potent activator of the pro-inflammatory response but retains effective immunomodulatory activity.

Indexed as

TranscriptomeAdjuvants, ImmunologicHealthy VolunteersHumansImmunologic FactorsLeukocytesLipid ALipopolysaccharidesMicroarray AnalysisToll-Like Receptor 4Adjuvants, ImmunologicImmunologic FactorsLipid ALipopolysaccharidesmonophosphoryl lipid AToll-Like Receptor 4

Identifiers

PMID28053314
PMCPMC5215261
OpenAlexW2568354677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.